's vaccine has received full approval from the Food and Drug Administration () for use in adults in the U.S., the company announced Monday.
Spikevax, as it has been named, is the second Covid vaccine to receive full approval from the FDA, joining 's Comirnaty. It was previously used on an emergency use authorization basis.
Full approval means the shot will still be available for use once the Covid-related state of emergency ends - which could be sometime this year. It also means the shot is being given an official stamp of approval from regulators that it is safe and effective over a long period of time.
Load More
Yorumlar
Kalan Karakter: